Navigation Links
Landmark report reveals immense burden of osteoporotic fractures in Europe
Date:6/15/2011

A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has been vastly underestimated. The report concludes that in Europe's five largest countries and Sweden alone, an estimated 2.5 million new fragility fractures occurred in 2010 the equivalent of 280 fractures per hour. It also showed an astounding eighty deaths per day attributable to fragility fractures.

'Osteoporosis: Burden, health care provision and opportunities in the European Union' examines both epidemiological and health economic aspects of osteoporosis and osteoporotic fractures in Europe, and specifically in France, Germany, Italy, Spain, UK as well as Sweden.

It is estimated that one in three women and one in five men over the age of fifty worldwide will sustain an osteoporotic fracture, often resulting in substantial pain and suffering, disability, and even death. As a result, osteoporosis imposes a significant burden on both the individual and society. IOF President John Kanis stated, "This landmark report exposes a number of major issues and challenges related to health care provision for fragility fractures. What is particularly striking is how the economic burden of fractures has increased in just over a decade. In 2000 the economic burden of fractures for the then European Union was estimated at 36 billion. The current estimate of 30.7 billion for just six countries largely reflects the increased number of fractures due to Europe's ageing population."

Several of the key findings regarding the economic and health cost of fragility fractures for the six countries studied include:

  • For the year 2010 approximately 2.5 million new fractures occurred in the six countries, with approximately 34,000 deaths caused by fractures 49% following hip fractures
  • The total health burden of osteoporotic fractures, measured in quality-adjusted life years (QALY) lost, was estimated at approximately 850,000 QALYs.
  • The health care cost, including pharmacological prevention, was estimated at Euro 30.7 billion corresponding to 3.5% of the total spending on health care in those countries.
  • A majority of the total costs was for the acute management of fracture whilst pharmacological prevention and treatment only represented 4.7% of total costs.
  • Despite the existence of management guidelines, a minority of patients receive medical treatment to prevent fractures.
  • In 2025 the projected number of fractures will increase by 29% reaching 3.2 million fractures, with health care costs increasing to Euro 38.5 billion.
  • Improved implementation of clinical guidelines to close this 'treatment gap' is cost-effective and could save almost 700,000 fractures by 2025.
  • The economic burden of osteoporotic fractures in these countries exceeds those for migraine, stroke, MS, and Parkinson's disease, and is similar to the burden of rheumatoid arthritis.

In six clearly defined chapters, it provides an introduction to osteoporosis and then reviews medical innovation and clinical progress in the management of osteoporosis, the epidemiology and burden of the disease, the current uptake of osteoporosis treatments and the future burden of fractures as a consequence of increasing treatment uptake.

EFPIA Director General Richard Bergstrm commented, " In Europe the number of elderly is set to increase markedly, with individuals expected to enjoy a longer life expectancy than ever before. We also know that the incidence of fractures rises progressively with age, and as a result we can expect the economic and social impact of fractures to increase significantly unless action is taken. Fortunately, we have a host of effective diagnostic and treatment options at our disposal it is time to implement these advances fully. "


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. OHSU Doernbecher Childrens Hospital conducts second phase of landmark Batten study
2. Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
3. Fruit flies use horizontal landmarks for altitude control, says Caltech research team
4. Landmark dental school study uses genetic test to help predict gum disease
5. Scripps Research team wins global race to achieve landmark synthesis of perplexing natural product
6. Moa get fewer: Landmark study
7. Carnegie donates landmark clones to biology
8. Landmark project to map genomics of complex ant systems
9. ACLU -- Myriad Genetics lawsuit will become landmark case
10. 150 years of Darwins landmark book spawns international conference
11. Landmark national study reveals significance of green practices in attractions industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, today provided an ... in the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings ... Office.  The IPR was initiated on only certain claims ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... 2016  Silk Therapeutics, Inc., today announced the closing of ... now raised a total of $10.25 million in Series A ... Series A2 round was led by existing investor The Kraft ... from new investors Lear Corporation and Highland Consumer Partners, as ... ; Richard Sackler , MD, with Summer Road, LLC; ...
Breaking Biology Technology: